- Home
- BDSX vs SPKL Comparison
BDSX vs SPKL Comparison
Compare BDSX & SPKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- SPKL
- Stock Information
- Founded
- BDSX 2005
- SPKL 2021
- Country
- BDSX United States
- SPKL United States
- Employees
- BDSX N/A
- SPKL N/A
- Industry
- BDSX Precision Instruments
- SPKL
- Sector
- BDSX Health Care
- SPKL
- Exchange
- BDSX Nasdaq
- SPKL Nasdaq
- Market Cap
- BDSX 215.3M
- SPKL 175.4M
- IPO Year
- BDSX 2020
- SPKL 2023
- Fundamental
- Price
- BDSX $0.88
- SPKL $10.72
- Analyst Decision
- BDSX Strong Buy
- SPKL
- Analyst Count
- BDSX 4
- SPKL 0
- Target Price
- BDSX $3.08
- SPKL N/A
- AVG Volume (30 Days)
- BDSX 359.8K
- SPKL 10.4K
- Earning Date
- BDSX 03-03-2025
- SPKL 01-01-0001
- Dividend Yield
- BDSX N/A
- SPKL N/A
- EPS Growth
- BDSX N/A
- SPKL N/A
- EPS
- BDSX N/A
- SPKL 0.19
- Revenue
- BDSX $65,562,000.00
- SPKL N/A
- Revenue This Year
- BDSX $46.97
- SPKL N/A
- Revenue Next Year
- BDSX $31.65
- SPKL N/A
- P/E Ratio
- BDSX N/A
- SPKL $57.83
- Revenue Growth
- BDSX 48.92
- SPKL N/A
- 52 Week Low
- BDSX $0.86
- SPKL $10.23
- 52 Week High
- BDSX $2.04
- SPKL $11.95
- Technical
- Relative Strength Index (RSI)
- BDSX 30.29
- SPKL 62.29
- Support Level
- BDSX $0.90
- SPKL $10.69
- Resistance Level
- BDSX $1.00
- SPKL $10.73
- Average True Range (ATR)
- BDSX 0.07
- SPKL 0.02
- MACD
- BDSX 0.00
- SPKL -0.00
- Stochastic Oscillator
- BDSX 3.41
- SPKL 80.00
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About SPKL Spark I Acquisition Corp.
Spark I Acquisition Corp is a Blank check company.